2,3-Dibromosuccinic acid

2,3-ジブロモこはく酸

CAS No. 526-78-3

2,3-Dibromobutanedioic acid

2,3-ジブロモブタン二酸

Molecular formula: C4H4O4Br2 Molecular weight: 275.88

ABSTRACT

2,3-Dibromosuccinic acid was studied for oral toxicity in rats in a single dose toxicity test at the 2000 mg/kg maximum dose level, and in a 28-day repeat dose toxicity test at doses of 0, 20, 140, and 1000 mg/kg/day. Genotoxicity of 2,3-dibromosuccinic acid was also studied by the reverse mutation assay in bacteria and the chromosomal aberration test in cultured Chinese hamster lung (CHL/IU) cells.

The single dose oral toxicity test revealed an LD50 of above 2000 mg/kg for both sexes.

In the repeat dose study, slight increased salivation was observed in males and females of the 1000 mg/kg/day group, but the frequency was only occasional at one or two times during the administration period. No test substance-related changes were noted in body weights, food consumption, and the findings obtained from hematology tests, blood chemical examination, urinalysis and pathological examination. The NOEL for the repeat dose toxicity is considered to be over 1000 mg/kg/day for both sexes.

2,3-Dibromosuccinic acid was not mutagenic in Salmonella typhimurium TA100, TA98, TA1535, TA1537 and Escherichia coli WP2 uvrA. Neither structural nor numerical chromosomal aberrations were induced in CHL/IU cells up to the concentration going 50% cell growth inhibition or the limit concentration of 10 mM, in the absence or presence of an exogenous metabolic activation system.

SUMMARIZED DATA FROM THE STUDIES

1. Single Dose Oral Toxicity 1)

Purity:99.8%
Test species/strain:Rat/Crj:CD (SD)
Test method:OECD Test Guideline 401
 Dosage:2000 mg/kg
 Number of animals:Male, 5; female, 5/group
 Vehicle:0.5% Sodium Carboxymethyl Cellulose solution
GLP:Yes

 Test results:
No abnormal clinical signs were found throughout the observation period. The body weights of all rats increased normally and autopsy revealed no abnormal findings.

LD50: Male, >2000 mg/kg; female, >2000 mg/kg

2. Repeat Dose Toxicity 1)

Purity:99.8%
Test species/strain:Rat/Crj:CD (SD)
Test method:Guidelines for 28-Day Repeat Dose Toxicity Testing for Chemicals (Japan)
 Route:Oral (gavage)
 Dosage:0 (vehicle), 20, 140, 1000 mg/kg/day
 Number of animals:Male, 6; female, 6/group
 Vehicle:0.5% Sodium Carboxymethyl Cellulose solution
 Administration period:Male and female, 28 days
 Terminal kill:Days 29 or 43
GLP:Yes

 Test results:
Slight increased salivation was observed in males and females of the 1000 mg/kg/day group, but the frequency was only occasional at one or two times during the administration period. No test substance-related changes were noted in terms of body weights, food consumption, and the findings obtained from hematology tests, blood chemical examination, urinalysis, and pathological examination.

The NOEL for the repeat dose toxicity is considered to be over 1000 mg/kg/day for both sexes.

3. Genetic Toxicity

3-1 Bacterial test 2)

Purity:> 98%
Test species/strains:S.typhimurium TA100, TA1535, TA98, TA1537 E. coli WP2 uvrA
Test method:Guidelines for Screening Mutagenicity Testing of Chemicals (Japan)
 Procedures:Plate incorporation method
 Solvent:Acetone
 Positive controls:-S9, AF-2 (TA100, WP2, TA98), sodium azide (TA1535) and 9-aminoacridine (TA1537) +S9, 2-aminoanthracene (all strains)
 Dosage:without metabolic activation 0, 156.3, 312.5, 625, 1250, 2500,5000 μg/plate metabolic activation method 0, 312.5, 625, 1250, 2500, 5000 μg/plate
 S-9:Rat liver, induced with phenobarbital and 5,6-benzoflavone
 Plates/test:3
 Number of replicates:2
GLP:Yes

 Test results:
Minimum concentration of test substance at which toxicity was observed:
No toxicity was observed up to a concentration of 5000 μg/plate with metabolic activation, while toxicity was observed at a concentration of 5000μg/plate without metabolic activation.

Genetic effects:
S. typhimurium TA100, TA1535, TA 98, TA1537
+?-
with metabolic activation[ ][ ][*]
without metabolic activation[ ][ ][*]

E. coli WP2 uvrA
with metabolic activation[ ][ ][*]
without metabolic activation[ ][ ][*]

3-2. Non-bacterial in vitro test (chromosomal aberration test) 2)

Purity:≧ 98%
Type of cell used:Chinese hamster CHL/IU cells
Test method:Guidelines for Screening Mutagenicity Testing of Chemicals (Japan)
 Solvent:Acetone
 Positive controls:-S9, Mitomycin C
+S9, Cyclophosphamide
 Dosage:-S9 (continuous treatment): 0, 0.3, 0.7, 1.3 mg/ml
-S9 (short-term treatment): 0, 0.7, 1.4, 2.8 mg/ml
+S9 (short-term treatment): 0, 0.7, 1.4, 2.8 mg/ml
 S-9:Rat liver, induced with phenobarbital and 5,6-benzoflavone
 Plates/test:2
GLP:Yes

 Test results:
Lowest concentration producing cytogenetic effects in vitro:
without metabolic activation (continuous treatment ): > 1.3 mg/ml
without metabolic activation (short-term treatment): > 2.8 mg/ml
with metabolic activation (short-term treatment): > 2.8 mg/ml

Genotoxic effects:
 clastogenicitypolyploidy
+?-+?-
without metabolic activation:[ ][ ][*][ ][ ][*]
with metabolic activation:[ ][ ][*][ ][ ][*]

1)The tests were performed by the Mitsubishi-Kasei Institute of Toxicological and Environmental Sciences (New name: Mitsubishi Chemical Safety Institute Ltd.), 14 Sunayama, Hasaki-machi, Kashima-gun, Ibaraki 314-02, Japan. Tel +81-479-46-2871 Fax +81-479-46-2874
2)The tests were performed by the Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano-shi, Kanagawa 257, Japan. Tel +81-463-82-4751 Fax +81-463-82-9627